Uncomplicated Lower UTI Treatment — MRCGP AKT MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Avoid urinary alkalinisers; review at 6 months and then annually
Explanation lettering: D = shown as A · A = shown as D
D is correct. Methenamine hippurate is an alternative prophylactic strategy in selected non-pregnant patients after current UTI is treated. Alkalinising products such as potassium or sodium citrate reduce its effectiveness and should be avoided. NICE advises review within 6 months and then every 12 months. A omits the initial review, B and E continue the interacting product, and C imposes an unsupported fixed 3-month stop.
Reference: NICE NG112: recurrent UTI antimicrobial prescribing: https://www.nice.org.uk/guidance/ng112/chapter/recommendations GMC: PA registration assessment content map: https://www.gmc-uk.org/education/standards-guidance-and-curricula/standards-and-outcomes/pa-and-aa-prequalification-education-framework/pa-registration-assessment-content-map